Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula
Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2022, to federal and state programs arising from its failure to manufacture certain powder infant formula and nutritional therapy products...
Se muestra el contenido original; la traduccion localizada aun no esta disponible.
Qué ocurrió
Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2022, to federal and state programs arising from its failure to manufacture certain powder infant formula and nutritional therapy products...
Por que importa
The development may change operating conditions or market expectations around Regulation. Further confirmation and measurable outcomes matter.
Entidades afectadas
Ver evidencia
1 articulos · 1 informe original · 1 independientes
- U.S. Department of JusticeFuente primaria · Respalda · EN · 100%Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula ↗
Afirmaciones
- Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula Observado
Conflictos
No se detectaron conflictos importantes en la evidencia disponible.
Cronología
- Primera publicación
Movimiento del mercado posterior al evento
La reacción del mercado aún no está disponible para este activo y periodo.